Lowered VAT Rate Transfer to the Consumer Prices: Selected Medicaments Case Study

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F60460709%3A41110%2F19%3A79334" target="_blank" >RIV/60460709:41110/19:79334 - isvavai.cz</a>

Výsledek na webu

—

DOI - Digital Object Identifier

—

Jazyk výsledku

čeština

Název v původním jazyce

Lowered VAT Rate Transfer to the Consumer Prices: Selected Medicaments Case Study

Popis výsledku v původním jazyce

The contribution focuses on changes in the tax burden on consumers following the introduction of a second reduced rate of value added tax on selected products. The shift in tax burden was assessed on a sample of specific pharmacy products that had been included in the second reduced VAT rate since 1st January 2015. Based on the pharmacy chain recommendations that provided the necessary data, the products were selected as a typical assortment sample, including contraception, high blood pressure medication, vaccine, antibiotics, and baby food. The provided data included mainly sales prices for final consumer for selected products in the months of 2014 and 2015. Data on sales prices were adjusted for inflation. The results show that the impact of the inclusion of selected products in the second reduced VAT rate on the final consumer price was positive. Reducing the VAT rate by including the price change set by the vendor and including inflation reduced the tax burden on the final consumer for all the pr

Název v anglickém jazyce

Lowered VAT Rate Transfer to the Consumer Prices: Selected Medicaments Case Study

Popis výsledku anglicky

The contribution focuses on changes in the tax burden on consumers following the introduction of a second reduced rate of value added tax on selected products. The shift in tax burden was assessed on a sample of specific pharmacy products that had been included in the second reduced VAT rate since 1st January 2015. Based on the pharmacy chain recommendations that provided the necessary data, the products were selected as a typical assortment sample, including contraception, high blood pressure medication, vaccine, antibiotics, and baby food. The provided data included mainly sales prices for final consumer for selected products in the months of 2014 and 2015. Data on sales prices were adjusted for inflation. The results show that the impact of the inclusion of selected products in the second reduced VAT rate on the final consumer price was positive. Reducing the VAT rate by including the price change set by the vendor and including inflation reduced the tax burden on the final consumer for all the pr

Druh

D - Stať ve sborníku

CEP obor

—

OECD FORD obor

50202 - Applied Economics, Econometrics

Projekt

—

Návaznosti

S - Specificky vyzkum na vysokych skolach

Rok uplatnění

2019

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název statě ve sborníku

European Financial Systems 2019: Proceedings of the 16th International Scientific Conference

ISBN

978-80-210-9338-6

ISSN

—

e-ISSN

—

Počet stran výsledku

8

Strana od-do

345-352

Název nakladatele

MASARYKOVA UNIV, ZEROTINOVO NAM 617-9, BRNO 601 77, CZECH REPUBLIC

Místo vydání

Brno, Czech Rep.

Místo konání akce

Brno, Czech Republic

Datum konání akce

24. 6. 2019

Typ akce podle státní příslušnosti

WRD - Celosvětová akce

Kód UT WoS článku

000503222600040